Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mohamed Ali, Sara A.R.Ayman Al Hendy. (2021) Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Review of Clinical Pharmacology 14:4, pages 427-437.
Read now
Read now
Manuela Farris, Carlo Bastianelli, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2019) Uterine fibroids: an update on current and emerging medical treatment options. Therapeutics and Clinical Risk Management 15, pages 157-178.
Read now
Read now
Fabio Barra, Carolina Scala, Valerio Mais, Stefano Guerriero & Simone Ferrero. (2018) Investigational drugs for the treatment of endometriosis, an update on recent developments. Expert Opinion on Investigational Drugs 27:5, pages 445-458.
Read now
Read now
Gian Benedetto Melis, Manuela Neri, Bruno Piras, Anna Maria Paoletti, Silvia Ajossa, Monica Pilloni, Maria Francesca Marotto, Valentina Corda, Alessandra Saba, Elena Giancane & Valerio Mais. (2018) Vilaprisan for treating uterine fibroids. Expert Opinion on Investigational Drugs 27:5, pages 497-505.
Read now
Read now
Mohamed Ali, Zunir Tayyeb Chaudhry & Ayman Al-Hendy. (2018) Successes and failures of uterine leiomyoma drug discovery. Expert Opinion on Drug Discovery 13:2, pages 169-177.
Read now
Read now
Articles from other publishers (51)
Andrea Etrusco, Fabio Barra, Vito Chiantera, Simone Ferrero, Stefano Bogliolo, Giulio Evangelisti, Engin Oral, Mariana Pastore, Alberto Izzotti, Renato Venezia, Marcello Ceccaroni & Antonio Simone Laganà. (2023) Current Medical Therapy for Adenomyosis: From Bench to Bedside. Drugs 83:17, pages 1595-1611.
Crossref
Crossref
Lucy HR Whitaker, Lee J Middleton, Lee Priest, Smita Odedra, Versha Cheed, Elaine P Nicholls, Alistair RW Williams, Neil Roberts, Clive E Stubbs, Konstantios Tryposkiadis, Hannah Bensoussane, Rohan Chodankar, Alison A Murray, Moira Nicol, Aleksandra O Tsolova, Kaiming Yin, Marcos Cruz, Hui Wei Leow, Lucy E Kershaw, Suzanne L McLenachan, Graham McKillop, Jane Walker, Scott I Semple, T Justin Clark, Mary Ann Lumsden, Dharani K Hapangama, Lucky Saraswat, Siladitya Bhattacharya, Paul Smith, Jane Daniels & Hilary OD Critchley. (2023) Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study. Efficacy and Mechanism Evaluation, pages 1-107.
Crossref
Crossref
Cristina Huerga López, Alicia Gutiérrez Alagüero & Ignacio Cristóbal García. (2023) Abordaje de los miomas uterinos: aproximación al tratamiento médico. Medicina Clínica 161, pages S15-S21.
Crossref
Crossref
Bahi ElbasuenyMaya Geerts, Emily C. Yang, Catherine Allaire, Paul J. Yong & Mohamed A. Bedaiwy. (2022) Medical treatments of endometriosis: a review. Reproductive and Developmental Medicine 7:3, pages 166-179.
Crossref
Crossref
K Yin, L Whitaker, E Hojo, S McLenachan, J Walker, G McKillop, C Stubbs, L Priest, M Cruz, N Roberts & H Critchley. (2023) Measurement of changes in uterine and fibroid volume during treatment of heavy menstrual bleeding (HMB). Human Reproduction Open 2023:3.
Crossref
Crossref
Suvitha Anbarasu & Anand Anbarasu. (2023) Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review. Medical Oncology 40:6.
Crossref
Crossref
Mohamed Ali, Michał Ciebiera, Somayeh Vafaei, Samar Alkhrait, Hsin-Yuan Chen, Yi-Fen Chiang, Ko-Chieh Huang, Stepan Feduniw, Shih-Min Hsia & Ayman Al-Hendy. (2023) Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics. Cells 12:8, pages 1117.
Crossref
Crossref
G Garuti, M Colonnelli, A Soliani, C Lubrano & M Soligo. (2023) Estro-progestin and progestogen intake: What’s the impact on hysteroscopic imaging?. Facts, Views and Vision in ObGyn 15:1, pages 61-67.
Crossref
Crossref
Mehmet Nuri DURAN, Hacı Öztürk ŞAHİN, Nihal KILINÇ & Bülent DEMİR. (2022) The Effect of Ulipristal Acetate on Surgical Endometriosis Created in RatsUlipristal Asetatın Ratlarda Oluşturulan Cerrahi Endometriozise Etkisi. Artuklu International Journal of Health Sciences 2:3, pages 15-19.
Crossref
Crossref
Oliwia W Mlodawska, Priyanka Saini, J Brandon Parker, Jian-Jun Wei, Serdar E Bulun, Melissa A Simon & Debabrata Chakravarti. (2022) Epigenomic and enhancer dysregulation in uterine leiomyomas. Human Reproduction Update 28:4, pages 518-547.
Crossref
Crossref
Varsha Jain, Rohan R. Chodankar, Jacqueline A. Maybin & Hilary O. D. Critchley. (2022) Uterine bleeding: how understanding endometrial physiology underpins menstrual health. Nature Reviews Endocrinology 18:5, pages 290-308.
Crossref
Crossref
Ranka Kanda, Yuko Miyagawa, Osamu Wada-Hiraike, Haruko Hiraike, Kazunori Nagasaka, Eiji Ryo, Tomoyuki Fujii, Yutaka Osuga & Takuya Ayabe. (2022) Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells. Heliyon 8:1, pages e08696.
Crossref
Crossref
Marcus-Hillert Schultze-Mosgau, Bart A. Ploeger, Matthias Frei, Joachim Höchel & Antje Rottmann. (2021) Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview. Clinical Pharmacokinetics 61:1, pages 1-16.
Crossref
Crossref
Kevin K. W. Kuan & Philippa T. K. Saunders. 2022. Nuclear Receptors in Human Health and Disease. Nuclear Receptors in Human Health and Disease
21
39
.
María Rosa Ramos Nieto, Marianela Lasagna, Gabriel Cao, Gloria Álvarez, Clarisa Santamaria, María Eugenia Rodriguez Girault, Nadia Bourguignon, Noelia Di Giorgio, Clara Ventura, Mariana Mardirosian, Horacio Rodriguez, Victoria Lux-Llantos, Claudia Cocca & Mariel Núñez. (2021) Chronic exposure to low concentrations of chlorpyrifos affects normal cyclicity and histology of the uterus in female rats. Food and Chemical Toxicology 156, pages 112515.
Crossref
Crossref
Rohan R. Chodankar, Alison Murray, Moira Nicol, Lucy H.R. Whitaker, Alistair R.W. Williams & Hilary O.D. Critchley. (2021) The endometrial response to modulation of ligand-progesterone receptor pathways is reversible. Fertility and Sterility 116:3, pages 882-895.
Crossref
Crossref
Sailaja Kamaraju, Amy M Fowler, Elizabeth Weil, Kari B Wisinski, Thu H Truong, Martin Lehr, Lubna N Chaudhary, Yee Chung Cheng, Christopher R Chitambar, Hallgeir Rui, Douglas Yee & Carol Lange. (2021) Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. Endocrinology 162:8.
Crossref
Crossref
Michael Oettel, Hans Joachim Zentel & Klaus Nickisch. (2021) A progestin isn’t a progestin: dienogest for endometriosis as a blueprint for future research – Review as a contribution for discussion -. Hormone Molecular Biology and Clinical Investigation 42:2, pages 133-142.
Crossref
Crossref
Simona MARTONE, Libera TROÌA, Paola MARCOLONGO & Stefano LUISI. (2021) Role of medical treatment of endometriosis. Minerva Obstetrics and Gynecology 73:3.
Crossref
Crossref
Marwa S. Hamza, Eman Ramadan & Salama A. Salama. (2021) Glucose and fatty acid metabolism involved in the protective effect of metformin against ulipristal-induced endometrial changes in rats. Scientific Reports 11:1.
Crossref
Crossref
Marcus‐Hillert Schultze‐Mosgau, Barbara Schütt, Corinna Draeger, Manuela Casjens, Stephanie Loewen, Torsten Zimmermann & Beate Rohde. (2020) The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial. British Journal of Clinical Pharmacology 87:3, pages 925-936.
Crossref
Crossref
Jingru Wang, Tairan Zhai, Xiao Sun, Xinran Du, Xinru Zhang, Xuemeng Shi, Yang Shu, Xiao Yan, Qingchang Xia & Yuxia Ma. (2021) Efficacy and safety of acupuncture for adenomyosis. Medicine 100:49, pages e28080.
Crossref
Crossref
C. Madhavrao & K. Mythili Bai. 2021. Introduction to Basics of Pharmacology and Toxicology. Introduction to Basics of Pharmacology and Toxicology
709
739
.
Huseyin Beyaz, Hasan Uludag, Doga Kavaz & Nahit Rizaner. 2021. Cell Biology and Translational Medicine, Volume 14. Cell Biology and Translational Medicine, Volume 14
163
181
.
Mohamed Ali, Zunir Tayyeb Chaudhry & Ayman Al-Hendy. 2020. Modern Management of Uterine Fibroids. Modern Management of Uterine Fibroids
22
27
.
Hilary O.D. Critchley, Elnur Babayev, Serdar E. Bulun, Sandy Clark, Iolanda Garcia-Grau, Peter K. Gregersen, Aoife Kilcoyne, Ji-Yong Julie Kim, Missy Lavender, Erica E. Marsh, Kristen A. Matteson, Jacqueline A. Maybin, Christine N. Metz, Inmaculada Moreno, Kami Silk, Marni Sommer, Carlos Simon, Ridhi Tariyal, Hugh S. Taylor, Günter P. Wagner & Linda G. Griffith. (2020) Menstruation: science and society. American Journal of Obstetrics and Gynecology 223:5, pages 624-664.
Crossref
Crossref
Kiriaki Papaikonomou, Caroline Frisendahl, Alistair R.W. Williams & Kristina Gemzell-Danielsson. (2020) Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology 252, pages 330-335.
Crossref
Crossref
Kristina Gemzell-Danielsson, Oskari Heikinheimo, Janos Zatik, Robert Poka, Tomasz Rechberger, Robert Hudecek, Kathrin Petersdorf, Francisco Ramirez, Thomas Faustmann, Esther Groettrup-Wolfers & Christian Seitz. (2020) Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2. European Journal of Obstetrics & Gynecology and Reproductive Biology 252, pages 7-14.
Crossref
Crossref
Hilary O. D. Critchley, Jacqueline A. Maybin, Gregory M. Armstrong & Alistair R. W. Williams. (2020) Physiology of the Endometrium and Regulation of Menstruation. Physiological Reviews 100:3, pages 1149-1179.
Crossref
Crossref
Fernando M Reis, Larissa M Coutinho, Silvia Vannuccini, Frédéric Batteux, Charles Chapron & Felice Petraglia. (2020) Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Human Reproduction Update 26:4, pages 565-585.
Crossref
Crossref
Inna S. Levina, Andrey K. Nazarov, Georgy V. Nazarov, Lidia E. Kulikova, Yury V. Kuznetsov, Andrey S. Dmitrenok, Dmitry V. Minin, Aleksey V. Aksenov & Igor V. Zavarzin. (2019) In vivo study on biotransformation of pentacyclic analogs of progesterone: Identification of their metabolites by HPLC-MS method. The Journal of Steroid Biochemistry and Molecular Biology 194, pages 105436.
Crossref
Crossref
Justin Tan, Paul Yong & Mohamed A. Bedaiwy. (2019) A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis. Current Opinion in Obstetrics & Gynecology 31:4, pages 212-221.
Crossref
Crossref
Andrea S. Lukes, David Soper, Amanda Harrington, Vilma Sniukiene, Yifan Mo, Patrick Gillard & Lee Shulman. (2019) Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas. Obstetrics & Gynecology 133:5, pages 869-878.
Crossref
Crossref
Christoph Steinbach, Petr Císař, Pavel Šauer, Jana Klicnarová, Heike Schmidt - Posthaus, Oksana Golovko & Hana Kocour Kroupová. (2019) Synthetic progestin etonogestrel negatively affects mating behavior and reproduction in Endler's guppies (Poecilia wingei). Science of The Total Environment 663, pages 206-215.
Crossref
Crossref
Aaron DeBono, David R. Thomas, Lindsay Lundberg, Chelsea Pinkham, Ying Cao, J. Dinny Graham, Christine L. Clarke, Kylie M. Wagstaff, Sharon Shechter, Kylene Kehn-Hall & David A. Jans. (2019) Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity. Scientific Reports 9:1.
Crossref
Crossref
Linda D. Bradley, Sukhbir S. Singh, James Simon, Kristina Gemzell-Danielsson, Kathrin Petersdorf, Esther Groettrup-Wolfers, Xiaowei Ren, Michal Zvolanek & Christian Seitz. (2019) Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study. Fertility and Sterility 111:2, pages 240-248.
Crossref
Crossref
Katherine F. Roby. 2019. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Vahid Zarezade, Marzie Abolghasemi, Fakher Rahim, Ali Veisi & Mohammad Behbahani. (2018) In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment. Journal of Molecular Modeling 24:12.
Crossref
Crossref
Andrew W. Horne & Hilary O.D. Critchley. 2018. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
653
662
.
Thomas Rabe, Nicole Saenger, Andreas D. Ebert, Thomas Roemer, Hans-Rudolf Tinneberg, Rudy Leon De Wilde & Markus Wallwiener. (2018) Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate. BioMed Research International 2018, pages 1-12.
Crossref
Crossref
Maria Rosa Maduro. (2018) A Look Into the Promising World of Selective Progesterone Receptor Modulators. Reproductive Sciences 25:3, pages 309-310.
Crossref
Crossref
Athilakshmi Kannan, Arpita Bhurke, Regine Sitruk-Ware, Parameswaran G. Lalitkumar, Kristina Gemzell-Danielsson, Alistair R. W. Williams, Robert N. Taylor, Milan K. Bagchi & Indrani C. Bagchi. (2018) Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone. Reproductive Sciences 25:3, pages 320-328.
Crossref
Crossref
Silvia Vannuccini, Stefano Luisi, Claudia Tosti, Flavia Sorbi & Felice Petraglia. (2018) Role of medical therapy in the management of uterine adenomyosis. Fertility and Sterility 109:3, pages 398-405.
Crossref
Crossref
N. I. Tapilskaya, A. S. Dukhanin & R. I. Glushakov. (2018) Influence of drug treatment of symptomatic uterine leiomyoma on the quality of life of women. Problemy reproduktsii 24:4, pages 81.
Crossref
Crossref
Mohamed Ali & Ayman Al-Hendy. (2017) Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids†. Biology of Reproduction 97:3, pages 337-352.
Crossref
Crossref
Inge De Milliano, Dominique Van Hattum, Johannes C.F. Ket, Judith A.F. Huirne & Wouter J.K. Hehenkamp. (2017) Endometrial changes during ulipristal acetate use: A systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 214, pages 56-64.
Crossref
Crossref
Ally Murji, Lucy Whitaker, Tiffany L Chow & Mara L Sobel. (2017) Selective progesterone receptor modulators (SPRMs) for uterine fibroids. Cochrane Database of Systematic Reviews 2017:4.
Crossref
Crossref
Philippe Bouchard & Nathalie Chabbert-Buffet. (2017) The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology 40, pages 105-110.
Crossref
Crossref
L.H.R. Whitaker, A.A. Murray, R. Matthews, G. Shaw, A.R.W. Williams, P.T.K. Saunders & H.O.D. Critchley. (2017) Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium. Human Reproduction.
Crossref
Crossref
Claudia Tosti, Libera Troìa, Silvia Vannuccini, Lucia Lazzeri, Stefano Luisi & Felice Petraglia. (2016) Current and Future Medical Treatment of Adenomyosis. Journal of Endometriosis and Pelvic Pain Disorders 8:4, pages 127-135.
Crossref
Crossref
Xuan Che, Jianzhang Wang, Wenting Sun, Jiayi He, Qiming Wang, Danyang Zhu, Weili Zhu, Jing Zhang, Jie Dong, Jingui Xu, Feiyun Zheng, Jianwei Zhou, Weidong Zhao, Qiao Lin, Lingfang Ye, Xiumin Zhao, Zhengfen Xu, Yunyan Chen, Jing Wang, Wenlie Wu, Linyun Zhai, Yuanyuan Zhou, Jianguang Zheng & Xinmei Zhang. (2021) Mifepristone Treats Symptomatic Adenomyosis: A Multicentre, Randomized, Double-Blind and Placebo-Controlled Trial. SSRN Electronic Journal.
Crossref
Crossref